Status:
ACTIVE_NOT_RECRUITING
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
Lead Sponsor:
Mayo Clinic
Conditions:
Pancreatic Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Researchers are trying to determine how the length of antibiotic treatment in addition to octreotide after pancreatic surgery affects the amount of time subjects are hospitalized as well as how many s...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients undergoing a Whipple procedure for various diagnoses (neuroendocrine tumors, adenocarcinoma, benign cystic neoplasms, duodenal and ampullary malignancies, etc) who are deemed intermediate-high risk as per our institutional protocol as shown above.
- Patients \> 18 years of age
- Exclusion Criteria
- Negligible and low risk patients
- All patients undergoing arterial resection.
- Age \<18 years
- Currently pregnant
Exclusion
Key Trial Info
Start Date :
November 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04329039
Start Date
November 17 2020
End Date
December 31 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905